Search for: "Endo Pharmaceuticals Inc" Results 121 - 140 of 158
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
4 May 2011, 7:52 am by Tron Emptage
  Generic Opioid Products Generic Name Drug Name Applicant/Sponsors Fentanyl Fentanyl Extended Release Transdermal System Actavis   Fentanyl Fentanyl Extended Release Transdermal System Lavipharm Labs   Fentanyl Fentanyl Extended Release Transdermal System Mylan Technologies   Fentanyl Fentanyl Extended Release Transdermal System Teva Pharms   Fentanyl Fentanyl Extended Release Transdermal System Watson   Methadone … [read post]
22 Mar 2011, 4:21 pm by Marie Louise
General New IP resource for Pharma, Biotech and Chem – Compulsory licences, comparing national requirements (IP Think Tank) WIPO and India partner to protect traditional knowledge from misappropriation (WIPO) UN Rapporteur for the Right to Health asked to intervene in the TPP negotiation (KEI) Patents and doctors, and the USTR TPP text (KEI) Biotech industry losing interest in the therapeutic potential of RNAi (Patent Docs) India: The curious case of the ‘data exclusivity’ volte… [read post]
8 Dec 2010, 6:07 pm by Larry Jones
Other GnRH drugs include Watson Pharmaceuticals Inc's Trelstar and Endo Pharmaceuticals Holdings Inc's Vantas. [read post]
12 Oct 2010, 8:56 pm by Kelly
Highlights this week included: Aricept(Donepezil) –US: Declaratory judgment jurisdiction for subsequent Paragraph IV filers: Teva Pharmaceuticals USA, Inc. v. [read post]
13 Jun 2010, 9:35 pm by Patent Docs
Paddock Laboratories Inc. 1:10-cv-00501; filed June 9, 2010 in the District Court of Delaware • Plaintiffs: Allergan Inc.; Allergan USA Inc.; Allergan Sales LLC; Endo Pharmaceuticals Solutions Inc.; Supernus Pharmaceuticals Inc. [read post]
10 Jun 2010, 9:46 pm by Patent Docs
By James DeGiulio -- Endo Settles with Impax and Sandoz in Opana Patent Suits Endo Pharmaceuticals Inc. has settled patent infringement suits against Sandoz Inc. and Impax Laboratories Inc. over generic versions of painkiller Opana ER. [read post]
27 Apr 2010, 10:58 pm
Solstice International Partners et al (Docket Report) US: FTC annual report highlights the Commission’s patent settlement efforts (FDA Law Blog)   Products Adcirca (Tadalafil) – US: Declaratory judgement of non-infringement and invalidity based on ANDA to manufacture generic Adcirca: Synthon v Eli Lilly et al (Patent Docs) Amrix (Cyclobenzaprine) – US: Mylan seeks declaratory judgment of noninfringement, unenforceability and invalidity of Amrix patent, based on Mylan’s… [read post]
7 Apr 2010, 4:30 am
Sandoz Pharmaceuticals GmbH et al (EPLAW) Prilosec (Omeprazole) – US: AstraZeneca ordered to pay attorney’s fees for ‘baseless’ suit to protect Prilosec OTC: AstraZeneca AB et al. v. [read post]
4 Apr 2010, 9:55 pm by Patent Docs
Endo Pharmaceuticals Inc. 1:10-cv-00261; filed March 31, 2010 in the District Court of Delaware Infringement of U.S. [read post]
18 Mar 2010, 2:30 am
(Patent Docs) Opana (Oxymorphone) - US: District Court New Jersey: Patent infringement complaint following a Paragraph IV Certification: Endo Pharmaceuticals Inc. et al. v. [read post]
3 Mar 2010, 5:05 am
(IP Osgoode) Australia: University of Western Australia’s application to appeal FCAFC’s decision in University of Western Australia v Gray fails (IP Whiteboard) Colombia/EU/Peru: Tough IP health provisions in Europe’s Colombia/Peru trade deal (IP Watch) (IP tango) EU: Something more about Swiss type claims: G02/08 (SiNApSE) (SiNApSE) US: Pharmaceutical patent settlements – and what about patients? [read post]
3 Mar 2010, 5:05 am
(IP Osgoode) Australia: University of Western Australia’s application to appeal FCAFC’s decision in University of Western Australia v Gray fails (IP Whiteboard) Colombia/EU/Peru: Tough IP health provisions in Europe’s Colombia/Peru trade deal (IP Watch) (IP tango) EU: Something more about Swiss type claims: G02/08 (SiNApSE) (SiNApSE) US: Pharmaceutical patent settlements – and what about patients? [read post]
11 Dec 2009, 11:13 am by Tom Lamb
This December 2009 FDA MedWatch alert also provided links to:  (1) "Prescribing Information" -- also known as the package insert or label -- for Voltaren Gel; and, (2)  a "Dear Healthcare Professional Letter" -- commonly called a "Dear Doctor" letter -- from Endo Pharmaceuticals Inc. and Novartis Consumer Health, Inc., the companies responsible for Voltaren Gel in the U.S. [read post]
1 Dec 2009, 9:45 am by Karen E. Keller
(patent infringement) 11/19: Allergan Inc., Allergan USA Inc., Allergan Sales, LLC, Endo Pharmaceuticals Solutions Inc., Supernus Pharmaceuticals Inc. v. [read post]
8 Oct 2009, 6:05 am
Reddy’s, Barr and Purepac (Patent Baristas) Renagel (Sevelamer) – US: Genzyme files patent infringement suit against Endo Pharmaceuticals following Para IV challenge (Patent Docs) Roundup Ready cotton seed – US: Monsanto files patent infringement suits against Brent M Hargrove and Larry H Lytle based on defendants’ use of cotton seed produced from earlier planted Roundup Ready cotton seed (Patent Docs) Seroquel (Quetiapine) – US:… [read post]